How is the Neurocrine Biosciences, Inc. today?

The Neurocrine Biosciences, Inc. today is trading in the down by -2.21% at 117.77.

How has Neurocrine Biosciences, Inc. performed historically?

The Neurocrine Biosciences, Inc. is currently trading down -2.21% on an intraday basis in the past week the index rose 7.31%. The index has been up 0.50% in the past quarter and fell -13.85% in the past year. You can view this in the overview section.

What is Neurocrine Biosciences, Inc. Annual Revenue?

Neurocrine Biosciences, Inc. Annual Revenue rose 24.81%, in the last year to $2,355.3 M. Its sector's average revenue growth for the last fiscal year was 8.63%.

What is Neurocrine Biosciences, Inc. Annual Net Profit?

Neurocrine Biosciences, Inc. Annual Net Profit rose 36.68% in the last year to $341.3 M. Its sector's average net profit growth for the last fiscal year was -7.36%.

What is Neurocrine Biosciences, Inc. Price to Earning Ratio?

Neurocrine Biosciences, Inc. Price to Earning Ratio is 38.11, higher than its sector PE ratio of 4.41.

What is Neurocrine Biosciences, Inc. Stock Price?

Neurocrine Biosciences, Inc. Stock Price fell 13.85% and underperformed its sector by 19.54% in the past year.

What is Neurocrine Biosciences, Inc. Quarterly Revenue?

Neurocrine Biosciences, Inc. Quarterly Revenue rose 11.12% YoY to $572.6 M. Its sector's average revenue growth YoY for the quarter was 2.79%.

What is Neurocrine Biosciences, Inc. Quarterly Net profit?

Neurocrine Biosciences, Inc. Quarterly Net profit fell 81.8% YoY to $7.9 M. Its sector's average net profit growth YoY for the quarter was -225.17%.

What is Neurocrine Biosciences, Inc. Debt to Equity Ratio?

Neurocrine Biosciences, Inc. Debt to Equity Ratio of 0.18 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Neurocrine Biosciences, Inc. Return on Equity(ROE)?

Neurocrine Biosciences, Inc. Return on Equity(ROE) for the last financial year was 14.16%, in the normal range of 10% to 20%.

What is Neurocrine Biosciences, Inc. Mutual Fund Holding?

Neurocrine Biosciences, Inc. Mutual Fund Holding increased by 3.26% in the last quarter to 74.49.

What is Neurocrine Biosciences, Inc. Promoter Share Holding?

Neurocrine Biosciences, Inc. Promoter Share Holding stayed the same in the most recent quarter at 1.36%.

What is Neurocrine Biosciences, Inc. Interest Coverage Ratio?

Neurocrine Biosciences, Inc. Interest Coverage Ratio is 4.84, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Neurocrine Biosciences, Inc. Institutional Holding?

Neurocrine Biosciences, Inc. Institutional Holding increased by 0.2% in the last quarter to 96.66.

Neurocrine Biosciences, Inc. XNAS: NBIX

Neurocrine Biosciences, Inc. Live Share Price Today, Share Analysis and Chart

Name: Neurocrine Biosciences, Inc.: Is Infosys Ltd. worth buying?
Item: Neurocrine Biosciences, Inc.
Rating: 1.917013875
Author: Trendlyne DVM scores

Expensive Performer

about

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

117.77 -2.66 (-2.21%)

25.45% Fall from 52W High

443.0K XNAS Volume

XNAS 13 May, 2025 12:38 PM (EDT)

Board Meeting

The next board meeting for Neurocrine Biosciences, Inc. is on 22 May 2025 for the purpose of Neurocrine Biosciences Inc Annual General Meeting for 2025 See details

Medium Financial Strength

38.9 / 100

Expensive Valuation

26.3 / 100

Technically Neutral

49.3 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

159

1Yr Price target upside is 35%

25 analysts

Neurocrine Biosciences, Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Neurocrine Biosciences, Inc. Live Share Price Today, Share Analysis and Chart

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

25.45% Fall from 52W High

SWOT Analysis

Neurocrine Biosciences, Inc. Live Price Chart

Neurocrine Biosciences, Inc. FAQ

How is Neurocrine Biosciences, Inc. today?

Neurocrine Biosciences, Inc. today is trading in the red, and is down by -2.21% at 117.77.

How has Neurocrine Biosciences, Inc. performed historically?

Neurocrine Biosciences, Inc. is currently trading down -2.21% on an intraday basis. In the past week the stock rose 7.31%. stock has been up 0.50% in the past quarter and fell -13.85% in the past year. You can view this in the overview section.